Companies / Blank Bio
RNA foundation models trained on tumour transcriptomes for patient stratification and biomarker discovery in oncology.
blank.bio| Round | Date | Amount | Investors |
|---|---|---|---|
| Seed | May 19, 2026 | US$7.2M | Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire, Y Combinator. Oversubscribed seed with Define Ventures, Leonis Capital, Nova Threshold, Ripple Ventures, SignalFire and Y Combinator; no lead named; strategic collaboration with PacBio announced same day |
Data as of September 26, 2026. Suggest a correction